| scholarly article | Q13442814 |
| P50 | author | Michael Karin | Q1458081 |
| Elisabeth Glitzner | Q41133405 | ||
| Maria Sibilia | Q41133496 | ||
| Hayato Nakagawa | Q80174875 | ||
| Ling Yang | Q87742475 | ||
| P2093 | author name string | Jan Tuckermann | |
| Ekihiro Seki | |||
| Jessica Zucman-Rossi | |||
| Mark A Valasek | |||
| Laura Antonucci | |||
| Sooyeon Lee | |||
| Stefano Caruso | |||
| Debanjan Dhar | |||
| Ju Youn Kim | |||
| Shabnam Shalapour | |||
| Kerstin Minnich | |||
| P2860 | cites work | DNA Damage, Aging, and Cancer | Q22121931 |
| Alcohol metabolism | Q24621827 | ||
| Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma | Q27487515 | ||
| In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 | Q27642888 | ||
| Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair | Q37357884 | ||
| Stem cells and cancer of the stomach and intestine | Q37769649 | ||
| CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? | Q37851351 | ||
| Zonation of glucose and fatty acid metabolism in the liver: Mechanism and metabolic consequences | Q38116295 | ||
| Tumor-Suppressor Functions of the TP53 Pathway | Q38824332 | ||
| Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation | Q39003817 | ||
| Histone H2AX Phosphorylation: A Marker for DNA Damage | Q39286636 | ||
| Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation | Q39750898 | ||
| HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation | Q40767550 | ||
| Identification of Sox9-Dependent Acinar-to-Ductal Reprogramming as the Principal Mechanism for Initiation of Pancreatic Ductal Adenocarcinoma | Q41856856 | ||
| Single-cell spatial reconstruction reveals global division of labour in the mammalian liver | Q42320342 | ||
| Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1 | Q42766950 | ||
| Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity | Q46066476 | ||
| IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis | Q46576855 | ||
| Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo | Q46868554 | ||
| IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice | Q51369659 | ||
| Expression pattern of Wnt signaling components in the adult intestine | Q52042359 | ||
| CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets | Q52173790 | ||
| TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. | Q53299056 | ||
| Chemical composition and tissue distribution of the human CDw44 glycoprotein | Q54352509 | ||
| A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection | Q57756525 | ||
| Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration | Q70988072 | ||
| Ras, protein kinase C zeta, and I kappa B kinases 1 and 2 are downstream effectors of CD44 during the activation of NF-kappa B by hyaluronic acid fragments in T-24 carcinoma cells | Q73407060 | ||
| Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival | Q73444664 | ||
| Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma | Q80522943 | ||
| p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling | Q28117922 | ||
| CD44: from adhesion molecules to signalling regulators | Q28201701 | ||
| Hepatocellular carcinoma: epidemiology and molecular carcinogenesis | Q28306363 | ||
| Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway | Q28505373 | ||
| Live or let die: the cell's response to p53 | Q29547663 | ||
| Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production | Q29614596 | ||
| Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression | Q29615766 | ||
| Suppression of induced pluripotent stem cell generation by the p53-p21 pathway | Q29619160 | ||
| Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding | Q30308636 | ||
| The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit | Q30577210 | ||
| Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling | Q33588191 | ||
| The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors | Q33613105 | ||
| Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis | Q33640296 | ||
| Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation | Q33737707 | ||
| Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma | Q33863710 | ||
| TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis | Q33944283 | ||
| A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus | Q33944754 | ||
| The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. | Q34164259 | ||
| EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation | Q34282375 | ||
| p53 Research: the past thirty years and the next thirty years. | Q34313764 | ||
| The p53 and Mdm2 families in cancer. | Q34493139 | ||
| Q2ChIP, a quick and quantitative chromatin immunoprecipitation assay, unravels epigenetic dynamics of developmentally regulated genes in human carcinoma cells | Q34608700 | ||
| CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression | Q34627193 | ||
| Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression | Q35568362 | ||
| Control of apoptosis by p53. | Q35603381 | ||
| CD44 is required for two consecutive steps in HGF/c-Met signaling. | Q35805198 | ||
| Hepatocyte transplantation into diseased mouse liver. Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes | Q35829671 | ||
| Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer | Q35985007 | ||
| The EGF receptor is required for efficient liver regeneration | Q36089334 | ||
| Dual Roles of MDM2 in the Regulation of p53: Ubiquitination Dependent and Ubiquitination Independent Mechanisms of MDM2 Repression of p53 Activity | Q36387594 | ||
| ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor | Q36653753 | ||
| Cancer stem cells in the development of liver cancer | Q36793453 | ||
| Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression | Q37152303 | ||
| Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis | Q37255168 | ||
| Acetylation and activation of STAT3 mediated by nuclear translocation of CD44. | Q37264062 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver cancer | Q623031 |
| P53 | Q7117920 | ||
| DNA damage response | Q30231004 | ||
| P304 | page(s) | 1061-1077.e6 | |
| P577 | publication date | 2018-06-01 | |
| P1433 | published in | Cancer Cell | Q280018 |
| P1476 | title | Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling | |
| P478 | volume | 33 |
| Q92841191 | Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis |
| Q59799713 | Akt2 causes TGFβ-induced deptor downregulation facilitating mTOR to drive podocyte hypertrophy and matrix protein expression |
| Q93004356 | Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside |
| Q99638475 | Deoxycholic Acid Upregulates the Reprogramming Factors KFL4 and OCT4 Through the IL-6/STAT3 Pathway in Esophageal Adenocarcinoma Cells |
| Q99630796 | Dietary Additives and Supplements Revisited: The Fewer, the Safer for Liver and Gut Health |
| Q91793987 | Elevated N-methyltransferase expression induced by hepatic stellate cells contributes to the metastasis of hepatocellular carcinoma via regulation of the CD44v3 isoform |
| Q132042442 | Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis |
| Q90471308 | IGFBP-3 Blocks Hyaluronan-CD44 Signaling, Leading to Increased Acetylcholinesterase Levels in A549 Cell Media and Apoptosis in a p53-Dependent Manner |
| Q98612825 | Long Non-Coding RNA LOXL1-AS1 Enhances Colorectal Cancer Proliferation, Migration and Invasion Through miR-708-5p/CD44-EGFR Axis |
| Q89995774 | Long non-coding RNA LINC00467 drives hepatocellular carcinoma progression via inhibiting NR4A3 |
| Q91162934 | MDM2-TP53 Crossregulation: An Underestimated Target to Promote Loss of TP53 Function and Cell Survival |
| Q89697426 | Matrix Effect in the Isolation of Breast Cancer-Derived Nanovesicles by Immunomagnetic Separation and Electrochemical Immunosensing-A Comparative Study |
| Q57300154 | Mevalonate Metabolism in Cancer Stemness and Trained Immunity |
| Q90450927 | Mouse Homolog of the Human TP53 R337H Mutation Reveals Its Role in Tumorigenesis |
| Q58595545 | New generation cancer therapy: right direction for sure with some uncertainty |
| Q102075253 | Proteoglycan-4 is correlated with longer survival in HCC patients and enhances sorafenib and regorafenib effectiveness via CD44 in vitro |
| Q64270114 | Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway |
| Q89612188 | Small Nucleolar RNA Host Gene 1 (SNHG1) and Chromosome 2 Open Reading Frame 48 (C2orf48) as Potential Prognostic Signatures for Liver Cancer by Constructing Regulatory Networks |
| Q90398809 | The Cancer Stem Cell in Hepatocellular Carcinoma |
| Q92236554 | The neuroprotective effect of bisperoxovandium (pyridin-2-squaramide) in intracerebral hemorrhage |
| Q96764448 | The role of MDM2-p53 axis dysfunction in the hepatocellular carcinoma transformation |
| Q64084449 | Transcriptome Analysis Revealed a Highly Connected Gene Module Associated With Cirrhosis to Hepatocellular Carcinoma Development |
| Q103002550 | UBC9 coordinates inflammation affecting development of bladder cancer |
| Q61805761 | circLARP4 induces cellular senescence through regulating miR-761/RUNX3/p53/p21 signaling in hepatocellular carcinoma |
Search more.